Cambridge, MA, United States of America

Ann Dak-Yee Kwong

USPTO Granted Patents = 7 


 

Average Co-Inventor Count = 22.4

ph-index = 5

Forward Citations = 83(Granted Patents)


Company Filing History:


Years Active: 2014-2020

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: Ann Dak-Yee Kwong: Pioneering Innovations in Influenza Virus Replication

Introduction:

Ann Dak-Yee Kwong is a trailblazer in the world of inventions, with a passion for innovation that drives her to push the boundaries of what is possible. Based in Cambridge, MA (US), she has made significant contributions to the field of medical science through her groundbreaking work.

Latest Patents:

With a portfolio of 7 patents to her name, Ann Kwong's latest patents focus on "Inhibitors of influenza viruses replication." These patents detail methods for inhibiting the replication of influenza viruses, reducing their presence in biological samples or patients, and treating influenza effectively using specific compounds represented by Structural Formula (I) or their pharmaceutically acceptable salts.

Career Highlights:

Ann Dak-Yee Kwong is a prominent figure at Vertex Pharmaceuticals, Inc., where she has harnessed her expertise to drive forward cutting-edge research and development initiatives. Her dedication to tackling challenging medical issues, such as influenza, has set her apart as a distinguished inventor in the pharmaceutical industry.

Collaborations:

In her collaborative efforts, Ann works closely with esteemed coworkers like Yi Zhou and Chao Lin, pooling their collective knowledge and skills to innovate new solutions in the realm of medical treatments. Together, they form a dynamic team that is dedicated to making a positive impact on healthcare through their inventive endeavors.

Conclusion:

In conclusion, Ann Dak-Yee Kwong's relentless drive for innovation, coupled with her focus on advancing medical treatments, establishes her as a true pioneer in the field of inventions. Her patented advancements in inhibiting influenza virus replication showcase her commitment to improving patient outcomes and shaping the future of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…